This result further supported the proposal that the overexpressed TRIB2 protein in the CRSC contributed to the Cisplatin-resistance and displayed the potential therapeutic benefits of the inhibition of overexpressed TRIB2 signaling in Cisplatin-resistant SCLC (Figure 4). Here, TRIB2 is linked to small cell lung carcinoma.